 Home > Medical News > Medicines Company News > Yuandong Biology is showing its power!

Yuandong Biology is showing its power!

 Last Update: 2021-05-02
 Source: Internet
 Author: User

Tags

medication database

victoza drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, Chengdu Yuandong Biotechnology has entered the administrative examination and approval stage with the imitation of four types of propofol fumarate tablets and dabigatran etexilate capsules, and approval will be imminent.

Yuandong Biological is approving varieties

Source: Meinenet MED2.

According to data from Mynet, the terminal sales of propofol tenofovir in China's public medical institutions in 2020H1 exceeded 100 million yuan, a year-on-year increase of 1952.

Dabigatran etexilate belongs to the β-alanine thrombin inhibitor, which is converted into dabigatran with direct anticoagulant activity in the body after oral absorption through the gastrointestinal tract.

Sales of terminal dabigatran etexilate in public medical institutions in China

Source: Mi Nei.

Currently, Dabigatran Etexilate Capsules have been approved for production by 3 domestic companies, including Chia Tai Tianqing Pharmaceutical Group, Jiangsu Hausen Pharmaceutical, and Chengdu Better Pharmaceutical.

Source: Minet database

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.